These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1578937)
1. IL-2 for the treatment of acute leukemias. Meloni G; Foa R; Capria S; Tosti S; Vignetti M; Gavosto F; Mandelli F Leukemia; 1992; 6 Suppl 2():28-30. PubMed ID: 1578937 [No Abstract] [Full Text] [Related]
2. Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission. Blaise D; Attal M; Reiffers J; Michallet M; Bellanger C; Pico JL; Stoppa AM; Payen C; Marit G; Bouabdallah R; Sotto JJ; Rossi JF; Brandely M; Hercend T; Maraninchi D Eur Cytokine Netw; 2000 Mar; 11(1):91-8. PubMed ID: 10705305 [TBL] [Abstract][Full Text] [Related]
3. [Bone marrow transplantation in the treatment of acute leukemias]. Moiseev SI; Ganapiev AA; Abdulkadyrov KM Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052 [TBL] [Abstract][Full Text] [Related]
4. Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study. Meloni G; Foà R; Tosti S; Vignetti M; Mancini F; Guarini A; Marchis D; Gavosto F; Mandelli F Leukemia; 1992 Aug; 6(8):780-5. PubMed ID: 1640729 [TBL] [Abstract][Full Text] [Related]
5. Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findings. Foa R; Meloni G; Tosti S; Novarino A; Fenu S; Guarini A; Cardona S; Gillio Tos A; Gavosto F; Mandelli F Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():98-102. PubMed ID: 2202476 [No Abstract] [Full Text] [Related]
6. [Allogenic bone marrow transplants in children with acute leukemia: preliminary results]. Madero L; Muñoz A; García-Laraña J; Pérez de Oteyza J; Durán R An Esp Pediatr; 1988 Oct; 29 Suppl 34():98-9. PubMed ID: 3063155 [No Abstract] [Full Text] [Related]
7. Generation of LAK cells in vitro in patients with acute leukemia. Parrado A; Rodriguez-Fernandez JM; Casares S; Noguerol P; Plaza E; Parody R; Espigado I; de Blas JM; Garcia-Solis D Leukemia; 1993 Sep; 7(9):1344-8. PubMed ID: 8371585 [TBL] [Abstract][Full Text] [Related]
8. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation. Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of acute leukemia by bone marrow transplantation]. Harada M Nihon Naika Gakkai Zasshi; 1994 Mar; 83(3):352-6. PubMed ID: 7963956 [No Abstract] [Full Text] [Related]
11. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome. Pawlowska AB; Davies SM; Orchard PJ; Wagner JE; Ramsay NK Bone Marrow Transplant; 1996 Aug; 18(2):453-5. PubMed ID: 8864463 [TBL] [Abstract][Full Text] [Related]
12. Adoptive cell-mediated immunotherapy with interleukin-2 (IL-2) for relapsing lymphoblastic crisis following mismatched unrelated bone marrow transplantation in a chronic myelogenous leukemia patient. Varadi G; Ackerstein A; Ben-Neriah S; Nagler A Bone Marrow Transplant; 1998 Jan; 21(1):93-6. PubMed ID: 9486502 [TBL] [Abstract][Full Text] [Related]
16. [Acute lymphoblastic leukaemia as a secondary malignoma after treatment of acute myeloic leukaemia (AML/M4)]. Hasanbegović E Med Arh; 2006; 60(5):315-6. PubMed ID: 16944736 [TBL] [Abstract][Full Text] [Related]
17. Allogenic bone marrow transplantation for leukemias and aplastic anemia. Tsai TW; Freytes CO Adv Intern Med; 1997; 42():423-51. PubMed ID: 9048126 [TBL] [Abstract][Full Text] [Related]
18. [Individualized treatment of leukemia patients by monitoring of minimal residual disease (MRD) based on WT1 assay]. Ogawa H; Sugiyama H Rinsho Ketsueki; 1998 Feb; 39(2):107-8. PubMed ID: 9545812 [No Abstract] [Full Text] [Related]